BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11778010)

  • 1. Reversible metronidazole-induced lesions of the cerebellar dentate nuclei.
    Woodruff BK; Wijdicks EF; Marshall WF
    N Engl J Med; 2002 Jan; 346(1):68-9. PubMed ID: 11778010
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversible metronidazole-induced cerebellar toxicity in a multiple transplant recipient.
    Graves TD; Condon M; Loucaidou M; Perry RJ
    J Neurol Sci; 2009 Oct; 285(1-2):238-40. PubMed ID: 19560788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible inferior colliculus lesion in metronidazole-induced encephalopathy: magnetic resonance findings on diffusion-weighted and fluid attenuated inversion recovery imaging.
    Lee SS; Cha SH; Lee SY; Song CJ
    J Comput Assist Tomogr; 2009; 33(2):305-8. PubMed ID: 19346865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible cerebellar lesions induced by metronidazole therapy for helicobacter pylori.
    Ito H; Maruyama M; Ogura N; Fujioka T; Iwasaki Y; Aikawa A; Hasegawa A
    J Neuroimaging; 2004 Oct; 14(4):369-71. PubMed ID: 15358960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metronidazole neurotoxicity: sequential neuroaxis involvement.
    Park KI; Chung JM; Kim JY
    Neurol India; 2011; 59(1):104-7. PubMed ID: 21339674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metronidazole-Induced Encephalopathy in Alcoholic Liver Disease: A Diagnostic and Therapeutic Challenge.
    Sonthalia N; Pawar SV; Mohite AR; Jain SS; Surude RG; Rathi PM; Contractor Q
    J Emerg Med; 2016 Oct; 51(4):e79-e83. PubMed ID: 27471133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Encefalopathy as a side effect of metronidazole therapy – a case report].
    Karayianni M; von Heijne A; Laska AC
    Lakartidningen; 2017 Mar; 114():. PubMed ID: 28323306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronidazole-induced reversible cerebellar dysfunction.
    John KJ; P Pillai D; Pillai V; John JK
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33526534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An 82-year-old man with ataxia and dysarthria.
    Vivas LLY; Gold WL; Mandell DM; Wu PE
    CMAJ; 2016 Dec; 188(17-18):1251-1254. PubMed ID: 26464138
    [No Abstract]   [Full Text] [Related]  

  • 10. Metronidazole-induced encephalopathy with contrast enhancing lesions on MRI.
    Furukawa S; Yamamoto T; Sugiyama A; Ohira K; Aotsuka Y; Koide K; Kojima K; Kuwabara S
    J Neurol Sci; 2015 May; 352(1-2):129-31. PubMed ID: 25865108
    [No Abstract]   [Full Text] [Related]  

  • 11. MR imaging and diffusion-weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxicity.
    Heaney CJ; Campeau NG; Lindell EP
    AJNR Am J Neuroradiol; 2003 Sep; 24(8):1615-7. PubMed ID: 13679281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal enhancing lesion of dentate nuclei causing neurologic symptoms induced by metronidazole toxicity.
    Deenadayalu VP; Orinion EJ; Chalasani NP; Yoo HY
    Clin Gastroenterol Hepatol; 2005 Mar; 3(3):xxix. PubMed ID: 15765436
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversible metronidazole-induced subacute cerebellar syndrome.
    Ng PS; Saini M
    QJM; 2014 Dec; 107(12):1051-2. PubMed ID: 24865263
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebellar ataxia following prolonged use of metronidazole: case report and literature review.
    Patel K; Green-Hopkins I; Lu S; Tunkel AR
    Int J Infect Dis; 2008 Nov; 12(6):e111-4. PubMed ID: 18511323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reversible changes on MR images in a patient with metronidazole-induced encephalopathy].
    Neshige S; Kanaya Y; Takeshima S; Yoshimoto T; Tanaka A; Kuriyama M
    Rinsho Shinkeigaku; 2015; 55(3):174-7. PubMed ID: 25786755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronidazole-induced encephalopathy and inferior olivary hypertrophy: lesion analysis with diffusion-weighted imaging and apparent diffusion coefficient maps.
    Seok JI; Yi H; Song YM; Lee WY
    Arch Neurol; 2003 Dec; 60(12):1796-800. PubMed ID: 14676060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronidazole-induced encephalopathy: a case report and review of the literature.
    Bottenberg MM; Hegge KA; Eastman DK; Kumar R
    J Clin Pharmacol; 2011 Jan; 51(1):112-6. PubMed ID: 20220041
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurological picture. MRI of metronidazole induced cerebellar ataxia.
    Moosa AN; Perkins D
    J Neurol Neurosurg Psychiatry; 2010 Jul; 81(7):754-5. PubMed ID: 20581140
    [No Abstract]   [Full Text] [Related]  

  • 19. Direct visualization of cerebellar nuclei in patients with focal cerebellar lesions and its application for lesion-symptom mapping.
    Maderwald S; Thürling M; Küper M; Theysohn N; Müller O; Beck A; Aurich V; Ladd ME; Timmann D
    Neuroimage; 2012 Nov; 63(3):1421-31. PubMed ID: 22892334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute reversible cerebellar lesions associated with metronidazole therapy.
    Bonkowsky JL; Sondrup C; Benedict SL
    Neurology; 2007 Jan; 68(3):180. PubMed ID: 17224569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.